MedPath

ACTAVIS INC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions

First Posted Date
2008-09-25
Last Posted Date
2010-08-17
Lead Sponsor
Actavis Inc.
Target Recruit Count
36
Registration Number
NCT00759759
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, Austin, Texas, United States

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions

First Posted Date
2008-09-25
Last Posted Date
2010-08-17
Lead Sponsor
Actavis Inc.
Target Recruit Count
36
Registration Number
NCT00759902
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, San Antonio, Texas, United States

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2008-09-25
Last Posted Date
2010-08-17
Lead Sponsor
Actavis Inc.
Target Recruit Count
36
Registration Number
NCT00759356
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, Austin, Texas, United States

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions

First Posted Date
2008-09-25
Last Posted Date
2010-08-17
Lead Sponsor
Actavis Inc.
Target Recruit Count
36
Registration Number
NCT00759915
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, San Antonio, Texas, United States

Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce

First Posted Date
2008-09-25
Last Posted Date
2010-08-17
Lead Sponsor
Actavis Inc.
Target Recruit Count
36
Registration Number
NCT00759954
Locations
๐Ÿ‡บ๐Ÿ‡ธ

CEDRA Clinical Research, LLC, Austin, Texas, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy